With selected research partners, we explore the future of risk coverage, assess changes in the risk landscape and act as a catalyst for industry change.
Meetings of the Swiss Re Strategic Council explore emerging issues and provide strategic insights, advice and recommendations on the global economic, political, regulatory ...
We expect the positive developments regarding COVID-19 vaccines to benefit growth in the second half of 2021. However, the economy will face headwinds in the first quarter from the fierce third wave of the pandemic and the current void of fiscal support. We expect an up to USD 1 trillion fiscal stimulus package, which will support growth in the first half of 2021.
Key takeaways
Positive developments on the vaccine front will support growth in the second half of next year.
We maintain our 2021 growth forecast of 3.5%, and revise upwards 2020 to -3.6%.
An up to USD 1 trillion fiscal stimulus package is expected for 2021.
We expect for Fed policy to be complemented with closer collaboration from the Treasury next year.
Economic Outlook
US Economic Outlook – Positive developments on vaccine front will support growth in second half of 2021
sigma research
Our data driven research publications, including the industry leading sigma, enable risk focussed decision making and identify strategic opportunities in the re/insurance industry.
